Getinge (OTCMKTS:GNGBY) Issues Earnings Results

Getinge (OTCMKTS:GNGBY) announced its quarterly earnings results on Friday. The company reported $0.38 earnings per share (EPS) for the quarter, Zacks reports. Getinge had a return on equity of 10.39% and a net margin of 6.92%.The business had revenue of $894.87 million during the quarter.

Getinge Stock Up 11.4%

GNGBY opened at $24.18 on Friday. The stock has a fifty day moving average of $20.65 and a 200-day moving average of $21.34. The company has a market capitalization of $6.59 billion, a P/E ratio of 23.03 and a beta of 0.96. Getinge has a fifty-two week low of $18.99 and a fifty-two week high of $24.67. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.86 and a current ratio of 1.32.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Getinge to a “hold” rating in a research report on Thursday, April 23rd. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.